Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Malaria Vaccines
Naval Medical Research Center publishes research in malaria vaccines
April 16th, 2008
New investigation results, 'Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity,' are detailed in a study published in Molecular and Biochemical Parasitology. According to recent research published in the journal Molecular and Biochemical Parasitology, "We have evaluated a technology called transcriptionally active PCR (TAP) for high throughput identification and prioritization of novel target antigens from genomic sequence data using the Plasmodium parasite, the causative agent of malaria, as a model. First, we adapted the TAP technology for the highly AT-rich Plasmodium genome, using...
Source: Vaccine Weekly (2008-04-16)
|
